Document:

Exhibit 10.134

 

AMENDMENT

 

This Amendment ("Amendment") to the Registration
Rights Agreement dated March 28, 2014 (the "Investment Agreement") and subsequent amendment dated May 9th, 2014 between
Dutchess Opportunity Fund, II, LP ("Dutchess") and VG Life Sciences, Inc., (the "Company") is made this 4th
day of September, 2014.

 

WHEREAS, it is in the best interest of both parties to
facilitate (the "Facilitation") the amendments in connection with the Investment Agreement.

 

NOW, THEREFORE, in consideration of the premises and
mutual covenants and agreements set forth herein and in reliance upon the representations and warranties contained herein, the
parties hereto covenant and agree as follows:

 

		1.	Amendment to the Registration Rights Agreement.

 

		a.	The Registration Rights Agreement is hereby amended to
DELETE in its entirety Section 2 (a) and contemporaneously the Registration Rights Agreement is hereby amended to INSERT the following
paragraph as the amended Section 2 (c):

 

		(a)	Subject to Section 3(g), the Company shall, within thirty
(30) days of the Company's clearing all SEC comments related to the Company's Form I 0 filing, file with the SEC the Registration
Statement or Registration Statements (as is necessary) on Form S-1 (or, if such form is unavailable for such a registration, on
such other form as is available for such registration), covering the resale of all of the Registrable Securities, which Registration
Statement(s) shall state that, in accordance with Rule 416 promulgated under the I 933 Act, such Registration Statement also covers
such indeterminate number of additional shares of Common Stock as may become issuable upon stock splits, stock dividends or similar
transactions. The Company will initially register for resale up to 10,000,000 shares of Common Stock, except to the extent that
the SEC requires the share amount to be reduced as a condition of effectiveness.

 

		2.	No other terms, rights or provisions of the Registration
Rights Agreement are or should be considered to have been modified by the terms of this Amendment and each party retains all other
rights, obligations, privileges and duties contained in Registration Rights Agreement that correspond respectively to the Registration
Rights Agreement including but not limited to the Investment Agreement between the Company and Dutchess.

 

 

Agreed and Accepted, and duly authorized to sign, on this 3rd
day of September. 2014

 

	By Dutchess:	/s/ Douglas H. Leighton
	 	Douglas H. Leighton, Managing Director
	 	 
	By Company:	/s/ John Tynan
	 	John Tynan, President and Chief Executive OfficerExhibit 10.135

 

EXHIBIT A(1)

 

VG LIFE SCIENCES INC.

CONVERTIBLE PROMISSORY NOTE

 

THIS CONVERTIBLE PROMISSORY
NOTE (“Note”) is issued as of September 16, 2014 (the “Original Issue Date”), by VG Life Sciences Inc.,
a Delaware corporation (the “Company”), in an aggregate principal amount of $50,000.00.

 

Terms not otherwise
defined herein shall have the meanings given in Section 6 below.

 

FOR VALUE RECEIVED,
the Company promises to pay to DW Odell Company, LLC, or registered assigns (the “Holder”), the principal sum of fifty
thousand dollars ($50,000.00), on or before July 9, 2016 (the “Maturity Date”) and to pay simple interest to the Holder
on the principal sum, at the rate per annum of eight percent (8%). Interest shall accrue daily commencing on the Original Issue
Date until payment in full of the principal sum, together with all accrued and unpaid interest, has been made or duly provided
for. Interest shall be calculated on the basis of a 360-day year. Interest hereunder will be due and payable at the Maturity Date,
to the person in whose name this Note is registered on the records of the Company (the “Note Register”). The principal
of, and interest on, this Note are payable in such coin or currency of the United States of America as at the time of payment is
legal tender for payment of public and private debts, at the address of the Holder last appearing on the Note Register. A transfer
of the right to receive principal and interest under this Note shall be transferable only through an appropriate entry in the Note
Register as provided herein.

 

This Note is subject
to the following additional provisions:

 

Section 1. Convertible
Note and Warrant Purchase Agreement. This Note is one of the Notes issued pursuant to that certain Convertible Note and Warrant
Purchase Agreement (the “Agreement”) between the Company and Holder dated as of July 9, 2014. This Note is subject
to, and qualified by, all the terms and conditions set forth in the Agreement.

 

Section 2.Events
of Default.

 

Section 2.1Events
of Default Defined; Acceleration of Maturity. If an Event of Default (as defined in the Agreement) has occurred then upon
the occurrence of any such Event of Default, the Holder may, by notice to the Company, declare the unpaid principal amount of
the Notes to be, and the same shall forthwith become, due and payable, without presentment, demand, protest or other notice of
any kind, all of which are hereby waived by the Company, together with the interest accrued thereon and all other amounts payable
by the Company hereunder and pursue all of Holder’s rights and remedies hereunder and under the other Loan Documents and
all other remedies available to Holder under applicable law.

 

 

    	1

    	 

    

 

Section 3.Optional
Conversion.

 

(a)The outstanding
principal and all accrued and unpaid interest of this Note shall be convertible, at the option of the Holder, into shares of common
stock of the Company (“Common Stock”) at the Conversion Ratio, at the option of the Holder, in four equal tranches
(25% each) on the following dates: October 9, 2015, January 9, 2016, April 9, 2016, and July 9, 2016. Any conversion under this
Section 3(a) shall be of a minimum amount of U.S. $5,000 of Notes. The Holder shall effect conversions by surrendering
the Notes (or such portions thereof) to be converted to the Company, together with the form of conversion notice attached hereto
as Exhibit A (the “Conversion Notice”) in the manner set forth in Section 3(h). Each Conversion Notice
shall specify the principal amount of Notes to be converted and the date on which such conversion is to be effected (the “Conversion
Date”). Subject to Section 3(b), each Conversion Notice, once given, shall be irrevocable. If the Holder is converting
less than all of the principal amount represented by the Note(s) tendered by the Holder with the Conversion Notice, the Company
shall promptly deliver to the Holder a new Note for such principal amount as has not been converted.

 

(b)Not later than
fifteen (15) Business Days after the Conversion Date, the Company will deliver to the Holder (i) a certificate or certificates
containing the restrictive legends and trading restrictions required by law, if any, representing the number of shares of Common
Stock being acquired upon the conversion of Notes and (ii) Notes in principal amount equal to the principal amount of Notes not
converted; provided, however that the Company shall not be obligated to issue certificates evidencing the shares of Common
Stock issuable upon conversion of any Notes, until Notes are either delivered for conversion to the Company or any transfer Holder
for the Notes or Common Stock, or the Holder notifies the Company that such Notes have been lost, stolen or destroyed and provides
a lost instrument indemnity to the Company to indemnify the Company from any loss incurred by it in connection therewith. If such
certificate or certificates are not delivered by the date required under this Section 3(b), the Holder shall be entitled
by written notice to the Company at any time on or before its receipt of such certificate or certificates thereafter, to rescind
such conversion, in which event the Company shall immediately return the Notes tendered for conversion.

 

(c)(i)The conversion
price (“Conversion Price”) for each Note in effect on any Conversion Date shall be $0.084, which is equal to 10% less
than the lowest consecutive 3 day average closing price during the period beginning July 15, 2014 and ending September 15, 2014,
subject to adjustment as otherwise contemplated by this Section 3(c).

 

(ii)In case of any Acquisition (as defined below)
of the Company, then Holder shall have the right thereafter to convert any principal and interest remaining owing under this Note
prior to the closing of any such Acquisition. At the election of Holder, Holder may convert this Note into the shares of stock
and other securities and property receivable upon or deemed to be held by holders of Common Stock following such Acquisition,
and the Holder shall be entitled upon such event to receive such amount of securities or property as the shares of the Common
Stock, into which the Note could have been converted immediately prior to such Acquisition, would have been entitled. The terms
of any such Acquisition shall include such terms so as to continue to give to the Holder the right to receive the securities or
property set forth in this Section 3(c) upon any conversion following such Acquisition. This provision shall similarly
apply to successive Acquisitions. “Acquisition” means (a) the closing of the sale, transfer or other disposition of
all or substantially all of the VGLS’s assets, (b) the consummation of the merger or consolidation of VGLS with or into
another entity (except a merger or consolidation in which the holders of capital stock of VGLS immediately prior to such merger
or consolidation continue to hold at least fifty percent (50%) of the voting power of the capital stock of VGLS or the surviving
or acquiring entity), or any transaction or series of transactions to which VGLS is a party in which in excess of fifty percent
(50%) of VGLS’s voting power is transferred, or (c) the exclusive license of all or substantially all of the intellectual
property of VGLS to a third party

 

    	2

    	 

    

 

 

(iii)The
Conversion Price shall be subject to adjustment as follows:

 

(A)In
case the Company shall (i) pay a dividend in shares of its capital stock, (ii) subdivide its outstanding shares of Common Stock,
(iii) combine its outstanding shares of Common Stock into a smaller number of shares, or (iv) issue by reclassification of its
shares of Common Stock any shares of the Company, the Conversion Price in effect immediately prior thereto shall be adjusted so
that the Holder of this Note thereafter surrendered for conversion shall be entitled to received the number of shares of Common
Stock which he would have owned or have been entitled to receive after the happening of any of the events described above, had
this Note been converted immediately prior to the happening of such event. Such adjustment shall be made whenever any of the events
listed above shall occur. An adjustment made pursuant to this subdivision (A) shall become effective retroactively immediately
after the record date in the case of a dividend and shall become effective immediately after the effective date in the case of
a subdivision, combination or reclassification.

 

(B)
If, at any time while this Note is outstanding, the Company takes any voluntary action or any event occurs as to which the
foregoing subdivisions are not strictly applicable, but the failure to make an adjustment in the Conversion Price hereunder would
not fairly protect the rights, without dilution, represented by this Note, then the Conversion Price in effect immediately prior
thereto shall be adjusted so that the Holder of this Note shall be entitled to receive the number of shares of Common Stock which
he would have owned or been entitled to receive after the happening of any such action or event, had this Note been converted
immediately prior to the happening of any such action or event.

 

(d)The
Company covenants that it will at all times reserve and keep available out of its authorized and unissued Common Stock solely
for the purpose of issuance upon conversion of Notes as herein provided, free from preemptive rights or any other actual contingent
purchase rights of persons other than the holders of Notes, such number of shares of Common Stock as shall be issuable upon the
conversion of the aggregate principal amount of all outstanding Notes. The Company covenants that all shares of Common Stock that
shall be so issuable shall, upon issue, be duly and validly authorized, issued and fully paid and nonassessable.

 

(e)
Upon a conversion hereunder the Company shall not be required to issue stock certificates representing fractions of shares
of Common Stock, but may, if otherwise permitted, make a cash payment in respect of any final fraction of a share based on the
Conversion Price at such time.

 

    	3

    	 

    

 

 

(f)The
issuance of certificates for shares of Common Stock on conversion of Notes shall be made without charge to the Holder for any
documentary stamp or similar taxes that may be payable in respect of the issue or delivery of such certificate, provided that
the Company shall not be required to pay any tax that may be payable in respect of any transfer involved in the issuance and delivery
of any such certificate upon conversion in a name other than that of the Holder and the Company shall not be required to issue
or deliver such certificates unless or until the person or persons requesting the issuance thereof shall have paid to the Company
the amount of such tax or shall have established to the satisfaction of the Company that such tax has been paid.

 

(g)Notes
converted into Common Stock shall be canceled.

 

(h)Each
Conversion Notice shall be given by email or mail, postage prepaid, addressed to the Controller of the Company of VG Life Sciences
Inc. located 121 Gray Avenue, Suite 200, Santa Barbara, CA 93101. Any such notice shall be deemed given and effective upon the
earliest to occur of (i) receipt of such email at the email address specified in this Section 3(h), (ii) five days after
deposit in the United States mails or (iii) upon actual receipt by the party to whom such notice is required to be given.

 

Section
4.Mandatory Conversion.

 

(a)In
the event Holder has not elected to convert all of the principal and interest remaining owing under this Note on or prior to two
years after the date of this note, the then outstanding principal and accrued and unpaid interest amount of this Note shall, without
further action by the Holder or the Company, be automatically converted in whole into that number of shares of Common Stock of
the Company at the Conversion Ratio on the Maturity Date (the “Mandatory Conversion Date”).

 

(b)Not
later than ten (10) Business Days after the Mandatory Conversion Date, the Company will deliver to the Holder a certificate or
certificates containing the restrictive legends and trading restrictions required by law, if any, representing the number of shares
of Common Stock being acquired upon the mandatory conversion of this Note; provided, however that the Company shall not
be obligated to issue certificates evidencing the equity securities issuable upon conversion of this Note, until the Note is either
delivered for conversion to the Company or any transfer Holder of the Note or Common Stock, or the Holder notifies the Company
that the Note have been lost, stolen or destroyed and provides a lost instrument indemnity or bond to the Company to indemnify
the Company from any loss incurred by it in connection therewith. The Company covenants and agrees that it shall comply with Sections
3(d) through (g) with respect to any mandatory conversion and such sections are incorporated by reference herein.

 

    	4

    	 

    

 

 

Section
5.Payment of Principal and Redemption.

 

(a)In
the event of an occurrence of an Event of Default, then the outstanding principal balance of this Note shall be due and payable
in full on the Maturity Date. Prior to the Mandatory Conversion Date this Note may not be prepaid.

 

(b)Nothing
in this Section 5 shall impair the Holder’s right to convert this Note pursuant to Section 3 prior to the Mandatory Conversion
Date.

 

Section
6.Definitions. For the purposes hereof, the following terms shall have the following meanings:

 

“Business
Day” shall mean any day, except a Saturday, Sunday or other day on which commercial banks in the State of California are
authorized or required by law to close.

 

“Conversion
Ratio” means, at any time, a fraction, of which the numerator is the outstanding principal amount represented by any Note
plus accrued but unpaid interest, and of which the denominator is the Conversion Price at such time.

 

“Original
Issue Date” means the date of the first issuance of this Note regardless of the number transfers hereof.

 

Section
7.Stockholder Rights. This Note shall not entitle the Holder to any of the rights of a stockholder of the Company,
including without limitation, the right to vote, to receive dividends and other distributions, or to receive any notice of, or
to attend, meetings of stockholders or any other proceedings of the Company, unless and to the extent converted into shares of
Common Stock in accordance with the terms hereof.

 

Section
8.Lost Note. If this Note shall be mutilated, lost, stolen or destroyed, the Company shall execute and deliver,
in exchange and substitution for and upon cancellation of a mutilated Note, or in lieu of or in substitution for a lost, stolen
or destroyed debenture, a new Note for the principal amount of this Note so mutilated, lost, stolen or destroyed but only upon
receipt of evidence of such loss, theft or destruction of such Note, and of the ownership hereof, and indemnity or bond, if requested,
all reasonably satisfactory to the Company.

 

Section
9.Governing Law. This Note shall be governed by and construed in accordance with the laws of the State of California,
without giving effect to conflicts of laws thereof.

 

Section
10.Notices. All notices or other communications hereunder shall be given, and shall be deemed duly given and received,
if given, in the manner set forth in Section 5(h).

 

 

    	5

    	 

    

 

Section
11.Waiver. Any waiver by the Company or the Holder a breach of any provision of this Note shall not operate as
or be construed to be a waiver of any other breach of such provision or of any breach of any other provision of this Note. The
failure of the Company or the Holder to insist upon strict adherence to any term of this Note on one or more occasions shall not
be considered a waiver or deprive that party of the right thereafter to insist upon strict adherence to that term or any other
term of this Note. Any waiver must be in writing.

 

Section
12. Severability. If any provision of this Note is invalid, illegal or unenforceable, the balance of this Note
shall remain in effect, and if any provision is inapplicable to any person or circumstance, it shall nevertheless remain applicable
to all other persons and circumstances.

 

IN
WITNESS WHEREOF, the Company has caused this instrument to be duly executed by an officer thereunto duly authorized as of the
date first above indicated.

 

 

VG LIFE SCIENCES
INC.,

a Delaware
corporation

 

 

By:    /s/
Haig Keledjian                        

Name:Haig
Keledjian

Title:Chairman

 

 

 

    	6

    	 

    

 

EXHIBIT A

 

NOTICE OF CONVERSION

AT THE ELECTION OF HOLDER

 

(To be Executed by the Registered Holder
in order to Convert the Note)

 

The undersigned hereby irrevocably elects
to convert the above Note into shares of Common Stock, no par value per share (the “Common Stock”), of VG Life Sciences
Inc. (the “Company”) according to the conditions hereof, as of the date written below. If shares are to be issued in
the name of a person other than undersigned, the undersigned will pay all transfer taxes payable with respect thereto and is delivering
herewith such certificates and opinions as reasonably requested by the Company in accordance therewith. No fee will be charged
to the Holder for any conversion, except for such transfer taxes, if any.

 

 

	Conversion calculations:	 
	 	Date to Effect Conversion
	 	 
	 	Principal Amount of Notes to be Converted
	 	 
	 	Applicable Conversion Price
	 	 
	 	Signature
	 	 
	 	Name:
	 	 
	 	Address:

 

 

 

    	7

    	 

    

 

Schedule of Cash Proceeds from DW Odell
Company, LLC 

and Received by VG Life Sciences Inc.

 

 

 

	July 9, 2014	 	$100,000.00
	 	 	 
	September 16, 2014	 	$50,000.00
	 	 	 
	 	 	$ __________
	Date: __________	 	 
	 	 	 
	 	 	$ __________
	Date: __________	 	 
	 	 	 
	 	 	$ __________
	Date: __________	 	 

 

 

 

    	8

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00236-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00236-of-00352.parquet"}]]